A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides.

We developed a multiplexed indirect immunofluorescent assay for antibodies to pneumococcal polysaccharides (PnPs) based on the Luminex multiple analyte profiling system (Luminex, Austin, TX). The assay simultaneously determines serum IgG concentrations to 14 PnPs serotypes: 1, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 12F; 14, 18C, 19F, and 23F. To assess the specificity of the multiplexed assay for each individual serotype, inhibition-of-binding studies were conducted using adult serum samples obtained after pneumococcal vaccination. Except for the closely related serotypes 9V and 9N, we demonstrated inhibition by homologous serotypes of more than 95% and inhibition by heterologous serotypes of less than 15% for all 14 PnPs serotypes. There was, however, high heterologous inhibition of 50% or greater with some serotypes. These cross-reacting antibodies could not be removed by preabsorption with pneumococcal C-polysaccharide but were removed by additional preabsorption with serotype 22F polysaccharide. The multiplexed Luminex assay showed good overall agreement with a well-established enzyme-linked immunosorbent assay that is currently recommended for evaluation of pneumococcal vaccine immunogenicity.

[1]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[2]  S. Szu,et al.  Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. , 1990, Microbial pathogenesis.

[3]  C. Frasch,et al.  Evaluation of Previously Assigned Antibody Concentrations in Pneumococcal Polysaccharide Reference Serum 89SF by the Method of Cross-Standardization , 1998, Clinical Diagnostic Laboratory Immunology.

[4]  H. Käyhty,et al.  Are the Enzyme Immunoassays for Antibodies to Pneumococcal Capsular Polysaccharides Serotype Specific? , 2000, Clinical Diagnostic Laboratory Immunology.

[5]  C. Frasch,et al.  Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent Assay , 2001, Clinical Diagnostic Laboratory Immunology.

[6]  D. Musher,et al.  Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection? , 1990, The Journal of infectious diseases.

[7]  M. Koskela.  Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination , 1987, The Pediatric infectious disease journal.

[8]  S. Quataert,et al.  Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S , 1995, Clinical and diagnostic laboratory immunology.

[9]  D. Musher,et al.  Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. , 1990, The Journal of infectious diseases.

[10]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[11]  G. Schiffman,et al.  Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. , 1987, Clinical immunology and immunopathology.

[12]  M. Rennels,et al.  Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants , 1998, Pediatrics.

[13]  R. W. Wright,et al.  Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. , 1986, Analytical biochemistry.

[14]  B. Gray,et al.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. , 1979, Journal of immunological methods.

[15]  G. Siber,et al.  Standardization of antibody assays for measuring the response to pneumococcal infection and immunization , 1989, The Pediatric infectious disease journal.

[16]  G. Overturf.  Technical Report: Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate and Polysaccharide Vaccines and Antibiotic Prophylaxis , 2000, Pediatrics.

[17]  R. Levinsky,et al.  Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood. , 1992, The Journal of infectious diseases.

[18]  M. Leinonen,et al.  Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine. , 1981, Journal of clinical pathology.

[19]  D. L. Klein,et al.  Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. , 1998, Vaccine.

[20]  S. Black,et al.  Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. , 1999, The Pediatric infectious disease journal.

[21]  R. Venezia,et al.  Modification of a direct enzyme-linked immunosorbent assay for the detection of immunoglobulin G and M antibodies to pneumococcal capsular polysaccharide , 1985, Journal of clinical microbiology.

[22]  M. Leinonen,et al.  A MULTI-LABORATORY EVALUATION OF AN ENZYME-LINKED IMMUNOASSAY QUANTITATING HUMAN ANTIBODIES TO STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDES , 2001, Immunological investigations.

[23]  C. Frasch,et al.  Pneumococcal Capsular Polysaccharide Preparations May Contain Non-C-Polysaccharide Contaminants That Are Immunogenic , 1999, Clinical Diagnostic Laboratory Immunology.